- Home
- NEWT vs LXRX Comparison
NEWT vs LXRX Comparison
Compare NEWT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEWT
- LXRX
- Stock Information
- Founded
- NEWT 1998
- LXRX 1995
- Country
- NEWT United States
- LXRX United States
- Employees
- NEWT N/A
- LXRX N/A
- Industry
- NEWT Major Banks
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- NEWT Finance
- LXRX Health Care
- Exchange
- NEWT Nasdaq
- LXRX Nasdaq
- Market Cap
- NEWT 365.7M
- LXRX 352.5M
- IPO Year
- NEWT N/A
- LXRX 2000
- Fundamental
- Price
- NEWT $13.45
- LXRX $0.74
- Analyst Decision
- NEWT Hold
- LXRX Buy
- Analyst Count
- NEWT 3
- LXRX 2
- Target Price
- NEWT $14.33
- LXRX $6.00
- AVG Volume (30 Days)
- NEWT 121.8K
- LXRX 4.9M
- Earning Date
- NEWT 11-06-2024
- LXRX 11-12-2024
- Dividend Yield
- NEWT 5.73%
- LXRX N/A
- EPS Growth
- NEWT 22.62
- LXRX N/A
- EPS
- NEWT 1.68
- LXRX N/A
- Revenue
- NEWT $316,405,000.00
- LXRX $5,229,000.00
- Revenue This Year
- NEWT N/A
- LXRX $886.38
- Revenue Next Year
- NEWT $6.55
- LXRX $181.58
- P/E Ratio
- NEWT $7.89
- LXRX N/A
- Revenue Growth
- NEWT 38.64
- LXRX 886.60
- 52 Week Low
- NEWT $10.07
- LXRX $0.62
- 52 Week High
- NEWT $15.49
- LXRX $3.73
- Technical
- Relative Strength Index (RSI)
- NEWT 45.24
- LXRX 38.05
- Support Level
- NEWT $13.06
- LXRX $0.72
- Resistance Level
- NEWT $14.44
- LXRX $0.85
- Average True Range (ATR)
- NEWT 0.39
- LXRX 0.09
- MACD
- NEWT -0.13
- LXRX 0.03
- Stochastic Oscillator
- NEWT 37.01
- LXRX 33.10
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions, It has developed a financial and technology-based business model that enables itself to acquire and process its clients in a very cost-effective manner. This capability is supported in large part by NewTracker, its patented prospect management technology software, that will allow NewtekOne clients to easily interact with NewtekOne subject matter experts in the areas of Banking, Lending, Payments, Technology, Payroll, and Insurance. It offers NewtekOne's clients a single online dashboard to access all of NewtekOne's business and financial solutions. It has four reportable segments Banking, Technology, NSBF, and Payments.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.